Caroline studied Biochemistry and Microbiology before specializing in Immunology, earning her PhD in Tim Tree’s group at King’s College London. During her PhD and subsequent postdoctoral research, she applied lentiviral TCR gene transfer to develop regulatory T cell therapies targeting autoimmune disease and transplant rejection. She then joined John Maher’s CAR mechanics group, before moving to Leucid Bio in 2018. At Leucid, she focuses on developing innovative armouring strategies to enhance CAR T cell therapies.